LAYA BUCHANAN: Open Payments
NPI 1841812377 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 11 payments from 5 companies in 2025. Trend: 2023 $222 · 2024 $358 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| ABBVIE INC. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, Auvelity.
Industry payments across TX — which companies pay providers there.
